1. Introduction
1.1 Report Guidance
1.2 Market Segmentation
2. Executive Summary
2.1 Key Market Insights
2.2 Market Attractiveness
3. Research Methodology
3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Data Triangulation and Validation
4. Asia Pacific Anticoagulant Reversal Drug Market Landscape
4.1 Overview
4.3 Ecosystem Analysis
- 4.3.1 List of Vendors in the Value Chain
5. Asia Pacific Anticoagulant Reversal Drug Market – Key Market Dynamics
5.1 Market Drivers
5.2 Market Restraints
5.3 Market Opportunities
5.4 Future Trends
5.5 Impact of Drivers and Restraints
6. Asia Pacific Anticoagulant Reversal Drug Market Regional Analysis
6.2 Asia Pacific Anticoagulant Reversal Drug Market Revenue 2017-2027 (US$ Million)
6.3 Asia Pacific Anticoagulant Reversal Drug Market Forecast Analysis
7. Asia Pacific Anticoagulant Reversal Drug Market Analysis – by Product
7.1 Prothrombin Complex Concentrates
- 7.1.1 Overview
- 7.1.2 Prothrombin Complex Concentrates: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.2 Vitamin K
- 7.2.1 Overview
- 7.2.2 Vitamin K: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.3 Protamine
- 7.3.1 Overview
- 7.3.2 Protamine: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.4 Tranexamic Acid
- 7.4.1 Overview
- 7.4.2 Tranexamic Acid: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.5 Idarucizumab
- 7.5.1 Overview
- 7.5.2 Idarucizumab: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
7.6 AndeXXa
- 7.6.1 Overview
- 7.6.2 AndeXXa: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
8. Asia Pacific Anticoagulant Reversal Drug Market Analysis – by End User
8.1 Hospital Pharmacies
- 8.1.1 Overview
- 8.1.2 Hospital Pharmacies: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
8.2 Retail Pharmacies
- 8.2.1 Overview
- 8.2.2 Retail Pharmacies: Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast, 2017-2027 (US$ Million)
9. Asia Pacific Anticoagulant Reversal Drug Market – Asia-Pacific Analysis
9.1 Overview
9.2 Asia-Pacific
- 9.2.1 Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Key
Country, 2020 and 2027 (%)
- 9.2.1.1 Asia Pacific Anticoagulant Reversal Drug Market – Revenue and
Forecast Analysis – by Country
- 9.2.1.1 China:
Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.1.1 China: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Product
- 9.2.1.1.2 China: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by End User
- 9.2.1.2 India:
Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.2.1 India: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Product
- 9.2.1.2.2 India: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by End User
- 9.2.1.3 Japan:
Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.3.1 Japan: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Product
- 9.2.1.3.2 Japan: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by End User
- 9.2.1.4 Australia:
Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.4.1 Australia: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Product
- 9.2.1.4.2 Australia: Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by End User
- 9.2.1.5 Rest of Asia-Pacific :
Asia Pacific Anticoagulant Reversal Drug Market – Revenue and Forecast to 2027 (US$ Million)
- 9.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by Product
- 9.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Anticoagulant Reversal Drug Market Breakdown, by End User
10. Competitive Landscape
10.1 Heat Map Analysis
10.2 Company Positioning and Concentration
11. Industry Landscape
11.1 Overview
11.2 Market Initiative
11.3 Partnerships and Collaborations
11.4 Other Developments
12. Company Profiles
12.1 Boehringer Ingelheim International GmbH
- 12.1.1 Key Facts
- 12.1.2 Business Description
- 12.1.3 Products and Services
- 12.1.4 Financial Overview
- 12.1.5 SWOT Analysis
- 12.1.6 Key Developments
12.2 Pfizer Inc
- 12.2.1 Key Facts
- 12.2.2 Business Description
- 12.2.3 Products and Services
- 12.2.4 Financial Overview
- 12.2.5 SWOT Analysis
- 12.2.6 Key Developments
12.3 Octapharma AG
- 12.3.1 Key Facts
- 12.3.2 Business Description
- 12.3.3 Products and Services
- 12.3.4 Financial Overview
- 12.3.5 SWOT Analysis
- 12.3.6 Key Developments
12.4 Fresenius Kabi AG
- 12.4.1 Key Facts
- 12.4.2 Business Description
- 12.4.3 Products and Services
- 12.4.4 Financial Overview
- 12.4.5 SWOT Analysis
- 12.4.6 Key Developments
12.5 Alexion Pharmaceuticals, Inc. (Portola Pharmaceuticals)
- 12.5.1 Key Facts
- 12.5.2 Business Description
- 12.5.3 Products and Services
- 12.5.4 Financial Overview
- 12.5.5 SWOT Analysis
- 12.5.6 Key Developments
12.6 CSL Limited
- 12.6.1 Key Facts
- 12.6.2 Business Description
- 12.6.3 Products and Services
- 12.6.4 Financial Overview
- 12.6.5 SWOT Analysis
- 12.6.6 Key Developments
12.7 Grifols, S.A.
- 12.7.1 Key Facts
- 12.7.2 Business Description
- 12.7.3 Products and Services
- 12.7.4 Financial Overview
- 12.7.5 SWOT Analysis
- 12.7.6 Key Developments
12.8 China Biologic Products, Inc
- 12.8.1 Key Facts
- 12.8.2 Business Description
- 12.8.3 Products and Services
- 12.8.4 Financial Overview
- 12.8.5 SWOT Analysis
- 12.8.6 Key Developments
12.9 Shanghai RAAS Blood Products Co., Ltd.
- 12.9.1 Key Facts
- 12.9.2 Business Description
- 12.9.3 Products and Services
- 12.9.4 Financial Overview
- 12.9.5 SWOT Analysis
- 12.9.6 Key Developments
13. Appendix
13.1 About Business Market Insights
13.2 List of Abbreviations
Get Free Sample For Asia Pacific Anticoagulant Reversal Drug Market
